Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback"

被引:11
作者
Kumana, CR
Ching, TY
Cheung, E
Kong, Y
Kou, M
Chan, CK
Chu, KM
Seto, WH
Lam, SK
机构
[1] Univ Hong Kong, Dept Med, Hong Kong, Peoples R China
[2] Univ Hong Kong, Qual Improvement Support Unit, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Pharm, Hong Kong, Peoples R China
[4] Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China
关键词
D O I
10.1016/S0009-9236(98)90141-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To determine whether immediate concurrent feedback (ICP) focused on inpatient omeprazole prescribing achieved more rational and cost-effective antiulcer drug prescribing and usage. Methods: In a 1400-bed teaching hospital, an audit (by specially trained personnel) was conducted to monitor inpatient prescribing of omeprazole (1) in preference to H-2-antagonists and other drugs according to agreed criteria (Helicobacter pylori eradication, severe reflux esophagitis, rapid ulcer healing deemed urgent because of severe symptoms or complications, high-dose steroid therapy of greater than or equal to 30 mg/day prednisolone) and (2) appropriateness of intravenous dosing (oral route not feasible or contraindicated), After baseline monitoring for 1 month, followed by relevant antiulcer drug therapy education, ICF was instituted for 1 year, This entailed explanatory memoranda requesting a change in prescribing issued to the respective medical teams of patients whose omeprazole prescription did not "conform," The main outcomes of the study were omeprazole prescription numbers per month and the proportion conforming, defined daily doses of antiulcer drugs used and corresponding expenditures, and pertinent antiulcer drug utilization data from 9 other local hospitals. Results: Baseline omeprazole prescribing conformed in 32 of 173 (18%) of the patients compared with 451 of 546 (83%) during institution of ICP (P < 0001; chi(2) test). Correspondingly, average overall omeprazole and ranitidine usage (inpatient and outpatient) and expenditure decreased (44% and 45%, respectively); collectively, use of less expensive alternatives increased about 61%, Estimated savings averaged about HK$150,000 ($20,000) per month, No comparable changes in usage were noted in 9 other local hospitals, Conclusion: Regarding hospital antiulcer drugs, this ICP strategy was associated with more rational prescribing and usage, and an important saving of resources.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 18 条
[1]  
Carpenter C E, 1993, QRB Qual Rev Bull, V19, P119
[2]   NONASSOCIATION OF ADRENOCORTICOSTEROID THERAPY AND PEPTIC-ULCER [J].
CONN, HO ;
BLITZER, BL .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (09) :473-479
[3]   OMEPRAZOLE VERSUS PLACEBO FOR ACUTE UPPER GASTROINTESTINAL-BLEEDING RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL [J].
DANESHMEND, TK ;
HAWKEY, CJ ;
LANGMAN, MJS ;
LOGAN, RFA ;
LONG, RG ;
WALT, RP .
BRITISH MEDICAL JOURNAL, 1992, 304 (6820) :143-147
[4]  
DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P111
[5]  
Fass R, 1997, AM FAM PHYSICIAN, V55, P205
[6]  
GREEN SB, 1976, NEW ENGL J MED, V294, P1291
[7]  
Hemeryck L, 1997, BRIT J CLIN PHARMACO, V43, P449
[8]  
*HLTH SERV DIR HLT, 1990, GUID ANT UT HLTH CAR
[9]   THE TREATMENT OF GASTRIC-ULCER WITH ANTISECRETORY DRUGS - RELATIONSHIP OF PHARMACOLOGICAL EFFECT TO HEALING RATES [J].
HOWDEN, CW ;
JONES, DB ;
PEACE, KE ;
BURGET, DW ;
HUNT, RH .
DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (05) :619-624
[10]   Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease [J].
Jaspersen, D ;
Schwacha, H ;
Schorr, W ;
Brennenstuhl, M ;
Raschka, C ;
Hammar, CH .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (10) :900-902